Campaign to educate customers on chronic pain management

VitalWear, Inc. (www.vitalwear.com), a leader in thermal compression medical devices announced that it is launching a Direct Mail and Web campaign in an effort to educate customers on a recent report from the Center for Disease Control (CDC), stating that among all diabetics, 52% suffer from arthritis.

The CDC report suggests that such co-morbidity inhibits patients from pursuing the physical activity and exercise needed to manage their condition. The campaign is targeted towards durable medical equipment providers (DME’s) and highlights the brand personality of the end user as a vital, active and engaged person. Visit www.vitalwear.com/cdcreport to download the report.

“In helping people relieve joint pain and inflammation, we hope they are better able to exercise and therefore, have better control of their diabetes and their overall health,” said Howard Edelman, VitalWear’s President and CEO. “The combined therapies of the VitalWrap System offer a safe and convenient solution in getting diabetics and arthritis sufferers up and moving again.”

By creating products especially tailored to the growing self-treatment markets in pain management, post-surgery rehab, and sports medicine, the patented technology enables both professionals and their patients to self-administer highly effective treatment, making VitalWear Systems the new standard of care for chronic pain management.

http://www.vitalwear.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triptans better at relieving migraine pain than recently marketed and more expensive drugs